As the mechanism of action of PTX is not associated directly with HR and/or HER2 status[51,52], in our study, we analyzed BC tissue specimens from patients with different subtypes of BC, mostly HR+ /HER2-, and we did not attempt to evaluate any correlation between PTX effect and BC subtypes. The gene discussed is ERBB2; the disease is breast cancer.